Filament CEO: Natural Psilocybin Is the Logical Option, So Why Is the Industry Stuck on Synthetic?

Filament Health Announces FDA Authorization Of Phase 2 Clinical Trial Studying Psilocybin For Alcohol Use Disorder And Post-Traumatic Stress Disorder In Veterans and First Responders

Just one single dose of ‘magic mushrooms’ could relieve depression for 5 years, researchers find

Filament Health Enters Into Exclusive License Agreement With University Of Alabama at Birmingham For Data From A Clinical Trial Of Psilocybin For The Treatment Of Cocaine Use Disorder